RxDoctor Payments Data

Patrick Clark

Medical · Sebring, FLNPI 1972609436

Payments from drug & device makers

$4,756in general payments, 2019–2025

Across 160 payments — averaging $29.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$991
  • Novo Nordisk$392
  • AbbVie$370
  • Amgen$284
  • E.r. Squibb & Sons, L.L.C.$226
  • Esperion Therapeutics, Inc.$181
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$4,756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,756 in reported general payments places this provider in the 85th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide49$61,256
EliquisApixaban23$24,515
FarxigaDapagliflozin Propanediol20$17,477
Atorvastatin Calcium271$2,497
SynthroidLevothyroxine Sodium31$1,985
Levothyroxine Sodium209$1,659
Omeprazole53$1,138
Tamsulosin Hcl108$1,071
Lisinopril157$981
Gabapentin74$968
Amlodipine Besylate141$931
Duloxetine Hcl48$790
Metoprolol Succinate67$758
Ezetimibe64$696
Mirtazapine48$633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$127$61,25649 claims
PfizerEliquis$137$24,51523 claims
AstraZenecaFarxiga$991$17,47720 claims
AbbVieSynthroid$370$1,98531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,031 medical providers in Florida.

Other medical in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →